US20180256824A1 - Seal Structures for Wet/Dry Automatic Injectors - Google Patents

Abstract

An automatic injection device including a housing, a chamber with a first compartment and a second compartment, and a seal structure between the compartments. The seal structure is initially in a sealing condition that seals the first compartment from the second compartment, where the seal includes a plug and an outer sealing member. The plug is slidably movable within the outer sealing member to convert the seal structure from the sealing condition to a mixing condition by opening a path between the first compartment and the second compartment. The automatic injection device also includes a needle assembly and an activation assembly. Activation of the activation assembly causes (1) pressurization of the first compartment, (2) the seal structure to convert from the sealing condition to the mixing condition, and (3) the first and second medicament components to be mixed and forced through the needle assembly.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
• This application is a continuation of U.S. patent application Ser. No. 12/784,595, filed May 21, 2010, which is a continuation of U.S. patent application Ser. No. 11/698,965, filed Jan. 26, 2007, now U.S. Pat. No. 7,749,190, which is a division of U.S. patent application Ser. No. 10/690,987, filed Oct. 23, 2003, now U.S. Pat. No. 7,621,887, which is a continuation-in-part of U.S. patent application Ser. No. 09/897,422, filed Jul. 3, 2001, now U.S. Pat. No. 6,641,561, and U.S. patent application Ser. No. 09/972,202, filed on Oct. 9, 2001, now U.S. Pat. No. 6,770,052, both of which claim priority to U.S. Provisional Applications Nos. 60/238,458, 60/238,448, and 60/238,447, all filed on Oct. 10, 2000. The contents of all these applications are incorporated by reference herein in their entireties.
BACKGROUND OF THE INVENTION
• The invention relates to drug delivery devices. More particularly, the invention relates to automatic injector assemblies capable of mixing two components of a medicament and then delivering the mixed medicament to an injection site.
• An automatic injector is a device that enables intramuscular (IM) or subcutaneous administration of a dosage of medicament. Generally, the medicament is stored as a liquid formulation which is then injected intramuscularly. An advantage of automatic injectors is that they contain a measured dosage of a liquid medicament in a sealed sterile cartridge. As such, automatic injectors allow for quick and simple IM injection of a liquid medicament in emergency situations without the need for measuring dosages. Another advantage of automatic injectors is that the administration of the medicament is accomplished without the user initially seeing the hypodermic needle through which the medicament is delivered, and without requiring the user to manually force the needle into the patient. This is particularly advantageous when the medicament is being self-administered.
• There are drawbacks associated with the long-term storage of medicament in a liquid formulation. For instance, some medicaments are not stable in solution and thus have a shorter shelf life than their solid counterparts. To address this concern, automatic injectors have been developed which store the medicament in solid form and mix the solid medicament with a liquid solution immediately prior to injection. These injectors, disclosed for example in U.S. Reissue Pat. No. 35,986, entitled “Multiple Chamber Automatic Injector,” (the disclosure of which is incorporated herein specifically by reference), however, require the user of the injector to manually rupture a sealing member between the solid and liquid components and then manually shake the injector body to expedite dissolution of the solid component prior to injection. This increases the time needed to administer a dose of the medicament. However, rapid delivery of the medicament is needed in many emergency medical situations (e.g., nerve gas and chemical agent poisoning). Other wet/dry injection devices have been expensive to manufacture or provide unsatisfactory mixing of components prior to injection. Therefore, there is a need for a cost-effective automatic injector that stores medicament in solid form that does not require manual premixing by the user.
SUMMARY OF THE INVENTION
• One aspect of the invention relates to an automatic injection device for automatically administering a medicament upon actuation thereof, where the device includes a housing, a chamber disposed in the housing having a first compartment and a second compartment, and a seal structure between the first compartment and the second compartment. The seal structure is initially in a sealing condition that seals the first compartment from the second compartment, and includes a plug and an outer sealing member that forms a peripheral seal with an interior wall of the chamber. The plug is slidably movable within the outer sealing member to convert the seal structure from the sealing condition to a mixing condition by opening a path between the first compartment and the second compartment through the seal structure. The plug also maintains the same orientation with respect to the outer sealing member as the plug moves to convert the seal structure from the sealing condition to the mixing condition. The automatic injection device further includes a needle assembly connected to the first compartment, and an activation assembly carried by the housing. Activation of the activation assembly causes: (1) pressurization of the first compartment, (2) the seal structure to convert from the sealing condition to the mixing condition, and (3) the first and second medicament components to be mixed and forced through the needle assembly.
• Another aspect of the invention relates to an automatic injection device containing a medicament for automatically administering the medicament upon actuation thereof, where the device includes a housing, a chamber disposed in the housing having a first compartment and a second compartment, and a seal structure between the first compartment and the second compartment. The seal structure is initially in a sealed condition to maintain the first compartment separate from the second compartment, where the seal structure converts to a mixing condition in response to activation of the device. The seal structure includes an outer sealing member that forms a peripheral seal with an interior wall of the chamber, and a plug spaced radially inward from the outer sealing member. The plug is in a first position where it is sealingly engaged with a surface of the outer sealing member to form a liquid-tight seal between the first and second compartments when the seal structure is in the sealed condition. The plug is in a second position when the seal structure is in the mixing condition. The plug then remains stationary in the second position as the liquid component flows through the seal structure and thereafter. The automatic injection device further includes a needle assembly connected to the chamber and an activation assembly disposed in the housing. Activation of the activation assembly causes: (1) pressurization of the first compartment, (2) the seal structure to convert from the sealed condition to the mixing condition, and (3) contents of the first and second compartments to be mixed and forced through the needle assembly.
• These and other aspects and advantages of the invention will be described below.
BRIEF DESCRIPTION OF THE DRAWINGS
• The invention will be described in conjunction with the following drawing figures, in which like reference numerals designate like elements, and in which:
• FIG. 1 is a longitudinal cross-sectional view of a wet/dry automatic injector assembly in accordance with an embodiment of the present invention;
• FIGS. 2A-2B illustrate longitudinal cross-sectional views of needle support assemblies in accordance with certain embodiments of the present invention;
• FIGS. 3A-3D illustrate cross-sectional side views of various cartridge or chamber configurations and corresponding needle assembly options according to certain embodiments of the present invention;
• FIG. 4 is an enlarged partial cross-sectional side view of a needle assembly/cartridge engagement according to another embodiment;
• FIGS. 5A-5D illustrate cross-sectional side views of various embodiments of a seal structure according to the present invention;
• FIG. 6A is a longitudinal cross-sectional side view of a seal structure in accordance with another embodiment of the present invention, wherein the movable sealing plug is in a closed sealing position blocking the flow of the liquid injection solution;
• FIG. 6B is a longitudinal cross sectional side view of seal structure similar to6A, but showing the movable sealing plug in an open by-pass position permitting the flow of the liquid injection solution;
• FIG. 6C is a lateral cross sectional view of the seal structure of the present invention taken through theline6C-6C inFIG. 6A;
• FIG. 6D is a lateral cross sectional view of the seal structure of the present invention taken through theline6D-6D inFIG. 6B;
• FIG. 7 is a longitudinal cross-sectional view of a wet/dry automatic injector cartridge or chamber configuration in accordance with another embodiment of the present invention;
• FIGS. 8A and 8B are longitudinal cross sectional views of two additional embodiments of sea] structures in accordance with the present invention;
• FIG. 9 is a longitudinal cross-sectional view of a chamber and needle assembly according to a further embodiment of the invention;
• FIG. 10 is a perspective view of an outer sealing member in the chamber and needle assembly ofFIG. 9;
• FIG. 11 is a front elevational view of the outer sealing member ofFIG. 10;
• FIG. 12 is a longitudinal sectional view of the outer sealing member ofFIG. 10, taken through Line12-12 ofFIG. 11;
• FIG. 13 is a perspective view of a tapered insert in the chamber and needle assembly ofFIG. 9;
• FIG. 14 is a front elevational view of the tapered insert ofFIG. 13;
• FIG. 15 is a longitudinal sectional view of the tapered insert in the chamber and needle assembly ofFIG. 13, taken through Line15-15 ofFIG. 14;
• FIG. 16 is a longitudinal sectional view of a portion of the needle assembly ofFIG. 9, illustrating a chamber behind die needle assembly filter; and
• FIGS. 17A-17F are sectional and partially sectional views of a chamber illustrating a process for filling it with dry and liquid medicament components.
DETAILED DESCRIPTION
• In the following description, the present invention is described in connection with a push button type auto injector, whereby the user removes an end cap assembly and presses a button to trigger the injection process. The present invention, however, is not limited to push button type automatic injectors; rather, it is contemplated that the present invention may be incorporated into a nose activated auto injector, as described for example in U.S. Pat. No. 5,354,286, the disclosure of which is hereby incorporated herein by reference for such teaching.
• FIG. 1 is a longitudinal cross-sectional view of anautomatic injector assembly10 in accordance with an embodiment of the present invention. Theautomatic injector assembly10 includes a generally hollow tubularplastic housing110. Generally, thehousing110 includes aninjection end111 and anactivation end112, as shown inFIG. 1. In the embodiment shown, anactuator assembly120 is inserted into the rearward end of thehousing110. Theactuator assembly120 is received within thehousing110 untilflange115 of asleeve member144 is captured within anannular groove117 on the interior surface ofhousing110. Aremovable safety cap130 is releasably secured to theactuator assembly120.
• Theactuator assembly120 may be of any conventional type as known in the art, such as that disclosed in commonly assigned U.S. Pat. No. 5,391,151 hereby incorporated by reference. The present invention employs a rear-end activating device, similar to that in the aforementioned U.S. Pat. No. 5,391,151, and is therefore only briefly described herein. Theactuator assembly120 includes anactivation button sleeve132 having internal activation surfaces134. The activation assembly further includes aplastic collet122 with a split rearward portion formingspring fingers136 as known in the art Thesafety cap130 has apin portion138 that extends between thespring fingers136 so as to keep them spread apart when the injector is in a storage condition. Thespring fingers136 terminate in semi-conical configurations including rearwardly facing slopingsurfaces139 and forwardly facingflat surfaces142. Thecollet122 is surrounded by acylindrical sleeve144 having inwardly extendingflange146 at the rearward end thereof. Thecollet122 has a forwardannular flange148. Acoil spring250 surrounds thecollet122 and is compressed between theflange148 andflange146. The colletflat surfaces142 are retained in engagement with the rearwardly facing surfaces of theflange146, and thus prevented from moving off of the flange surfaces by thepin138 when the injector is stored.
• To activate the injector, thesafety pin130 is manually pulled off of the rear end of the injector, thus removingpin138 from between thefingers136. Theactivation button132 can then be pushed inwardly, and as a result of the activation surfaces thereof,134 engages the slopingsurfaces139 of thespring fingers136. This forces thespring fingers136 inwards toward one another and off of the retaining surfaces of theflange146. Thecompressed spring250 is then free to release the stored energy therein to move thecollet122 forwardly under the force of the spring to affect an injection operation as will be described later in more detail.
• Theactuator assembly120 may be of any type known in the automatic injector art that employs releasable stored energy. For example, rather than employing a spring, it may employ a charge of compressed gas.
• Located within the interior of thehousing110 is a vial orchamber150, preferably made of glass, for containing both a liquid injection solution and a dry medicament, or other types of medicament portions, as appropriate. Thechamber150 is preferably a hollow cylinder, with a smooth cylindrical inner surface. The liquid injection solution is located within a wet portion orcompartment151 of thechamber150. The dry medicament is located within adry portion152 or compartment of thechamber150. It is contemplated that the dry medicament may be in powder, lyophilized, freeze-dried, or any other solid formulation known in the artA seal structure160 engages the interior side walls of thechamber150 to seal thedry portion152 from thewet portion151 and to prevent seepage of the liquid injection solution into thedry portion152 prior to activation of the injector assembly. Further, aneedle assembly140 mounts to the forward end of vial orchamber150 to inject the medicament upon activation of the injector assembly. In this embodiment, the forward end portion of thechamber150 has anannular groove153 formed therein for attachment of theneedle assembly140. Theneedle assembly140 includes a funnel-shapedneedle support143. The wide end of theneedle support143 has anannular rib145 that is snap-fit intogroove153 to form a seal with thechamber150. Theneedle support143 can be made of a resilient plastic material, or metal with a rubber seal that seats intogroove153. The forward narrow end147 (seeFIG. 2A) of theneedle support143 sealingly receives the rearward end ofhollow needle141. Theneedle support143 forms a sealed fluid channel from thechamber150 to theneedle141. Arubber needle sheath202 surrounds theneedle141 and receives thenarrow end147 of theneedle support143. Afilter190 is sealingly retained across the entire wide-end mouth of theneedle support143 by anannular sealing washer156. Alternatively, thefilter190 could be ultrasonically welded or otherwise secured to theneedle support143.
• FIGS. 2B, 3A, and 4 illustrate another embodiment of aneedle assembly140 andchamber150. Thechamber150 in this embodiment is known in the art as a dental cartridge. The dental cartridge has a cylindrical rear portion and a narrowed forward neck portion defining an outer annular groove1 S3. The forward end of the dental cartridge defines anannular flange portion154. In this embodiment, theneedle support143 has a rearwardannular flange155 that receives anannular sealing member156 that surrounds both sides offlange155. The sealingmember156 serves to seal afilter190 over the wide end of the funnel shapedneedle support143. The rearward surface of the sealingmember156 is sealingly clamped against the forward surface ofchamber flange154 by ametal retaining clamp157 as best seen inFIG. 4.
• As shown inFIG. 1,forward end1221 of thecollet122 extends into the rearward end ofchamber150 and is adapted to connect with aplunger170 rearwardly sealing thewet container151. Theplunger170 is adapted to sealingly engage the side wall of thewet container150 to prevent leakage of the contents (e.g., liquid injection solution) of thewet container151. Theplunger170 is preferably formed from a material having low factional properties such that thecollet122 andplunger170 may easily slide within thewet container150 when operated. Alternatively, theplunger170 may be lubricated with silicone or other suitable non-reactive lubricant The movement of thecollet122 and theplunger170 pressurizes the liquid located within thewet container151. A suitable medicament is located within adry container152.
• The embodiment ofFIGS. 1 and 2A is advantageous in that it has an open mouth configuration wherein the needle-end of the vial or chamber is not significantly narrowed or tapered. Such an open mouth configuration permits direct access to thedry portion152 ofchamber150 for easy loading. Further, the open mouth configuration aids in preventing cross contamination betweenwet portion151 anddry portion152 in that thedry portion152 does not have to be filled throughliquid portion151 ofchamber150.Needle assembly140 can be mounted to vial orchamber150 in a snap-on configuration (FIG. 3B), an internal mount configuration (FIG. 3C), or an external needle assembly configuration (FIG. 3D).
• As mentioned above, theseal structure160 is adapted to engage the interior side walls ofchamber150 to prevent passage of the contents (eg., liquid injection solution) ofwet portion151 into thedry portion152 prior to activation of the automatic injection assembly. Generally,seal structure160 can include anouter sealing member180, amovable sealing plug166, a by-pass zone165yat least oneflow path167, and preferably also includes a filter ormembrane164. With reference toFIG. 5A-D,seal structure160 can preferably be formed as a six piece (FIG. 5A), five piece (FIG. 5B), four piece (FIG. 5C), or three piece (FIG. 5D) configuration.
• More particularly, with reference toFIG. 5A, theouter sealing structure180 of the six piece configuration can comprise a two piece annularrigid body181 whereinmembers181a,131bthereof are formed into the two piece rigid body using, e.g., annular weld connections or other bonding techniques known in the art.Outer sealing structure180 can further include multipleexternal sealing members182, e.g., two O-rings, to provide an annular sealing engagement with the inner wall of vial orcompartment150. The sealingstructure180 further includes aninternal plug member166 and a filter ordispersion membrane164 as will be discussed in greater detail later.
• In another embodiment, as shown inFIG. 5B, rather than plural O-rings,outer sealing structure180 can include a singleexternal sealing member182, e.g., a unitary gasket, to provide an annular sealing engagement with the inner wall of vial orcompartment150. External sealingmember182 may optionally be secured to two piecerigid body181 using any bonding techniques known in the art. Further,rigid body members181a,181bmay be shaped such that they securingly engageexternal sealing members182 within notched recesses183. Alternately, sealingmembers182 may be secured torigid body members181a,181bby an interference fit. As with the first embodiment, a filter ormembrane164 is clamped in place at the proximal end offlow path167 betweenmember181aandmember181bof the two piece rigid body.
• In another embodiment, as shown inFIG. 5C,outer sealing structure180 comprises a unitary internalrigid member181 and anexternal sealing member182. Again, internalrigid member181 andexternal sealing member182 may optionally be secured together using any bonding techniques known in the art. Further, internalrigid member181 andexternal sealing member182 may be formed such that they securingly engage each other using a combination of notchedrecesses183 and extendingshoulders184. The filter ormembrane164 can be held in place between internalrigid member181 andshoulder184 ofexternal sealing member182. Alternatively, thefilter164 may be ultrasonically welded or otherwise secured to therigid member181. In yet another embodiment, as shown inFIG. 5D,outer sealing object180 can comprise a unitaryexternal sealing member182 which can optionally be molded so as to accommodate filter ormember164 within retainingrecess185.FIGS. 6A and 6B illustrate another embodiment that is very similar to that of FIGURE SA, but provides a slightly different shape for outer annularrigid body181 and particularly themembers181a,181bthereof.
• In each embodiment illustrated inFIGS. 5A-5D and 6A-6B, external sealingmember182 is preferably formed from a non-reactive elastomer material which can provide for the necessary sealing engagement with the inner wall of vial orcompartment150. Further, external sealingmember182 can optionally be lubricated with silicon or other suitable non-reaction lubricant to facilitate movement of theouter sealing object180 forwardly within vial orcompartment150 upon receiving sufficient force as will be described. Themovable sealing plug166 is preferably formed from a material, such as an elastomer or PTFE, having low factional properties such that the sealingplug166 may easily slide withinouter sealing object180 when the injector is activated. Themovable sealing plug166 may also optionally be lubricated with silicon or other suitable non-reactive lubricant In the embodiments illustrated, and as specifically shown inFIG. 6B, it is preferred that the outerannular structure180 defines an inner surface having a smooth cylindrical configuration towards therearward portion169 thereof, and longitudinally extendinggrooves168 towards the forward portion thereof. Thegrooves168 create a flowpath orflowpaths167 through which liquid in thewet compartment151 can bypassseal plug166 when theplug166 is moved forwardly from sealing engagement withcylindrical surface portion169 into thegrooved portion168. The movement of the sealingplug166 into the by-pass area165 opens thefluid flow path167 betweenwet portion151 anddry portion152. Themovable sealing plug166 preferably includes a plurality ofcircumferential grooves186 to provide for enhanced sealing engagement and to facilitate sliding action of theplug166.
• As mentioned above, theseal structure160 preferably includes filter ormembrane164 at the end offlow path167 through which the liquid injection solution may pass after the injector has been activated. The liquid injection solution then enters thedry portion152 of thechamber150 where it mixes with and dissolves the dry medicament More particularly, thefilter164 disperses the liquid injection solution exiting theseal structure160 to present laminar fluid flow to the full surface of the dry medicament, thereby wetting the entire surface of the dry medicament for rapid and complete dissolution. Thefilter membrane164 can be any structure that generally uniformly distributes the liquid across the entire diameter of thechamber150 for enhanced dissolution of the dry medicament.
• During operation, manual activation of theactuator assembly120 releases the collet122 (as described above), which applies pressure on theplunger assembly170. The application of pressure on theplunger assembly170 by the collet and spring assembly124 moves theplunger170 in the direction of theneedle assembly140. As a result, theentire chamber150 andneedle assembly140 are moved forwardly in thehousing110 such thatneedle141 pierces through the front end ofsheath202 and exits through the forward end of thehousing110, and particularly through ahole204 in the front nose-cone portion206 of the housing. Thesheath202, which serves to maintain theneedle141 sterile when the injector is in storage, also serves as a shock absorber during activation as it is compressed in generally accordion like fashion between thenose cone206 andneedle support143.
• When theneedle141 is extended from thehousing110 and thechamber150 andneedle support143 approach thenose cone206 portion of the housing so that Anther forward movement ofchamber150 is substantially resisted, theplunger170 then begins to travel forwardly through thechamber150. This pressurizes the liquid injection solution located within thewet compartment151. With reference toFIG. 6A-6B, the increased pressure within thewet compartment151 moves the sealingplug166 from a first sealed position wherein sealingplug166 is sealingly engaged withsurface169 of outer sealing structure180 (FIG. 6A) to a second by-pass position (FIG. 6B) that allows the injection solution to flow throughflow path167 created bygrooves168 and thereby throughseal structure160.
• As described above, the high pressure developed within thewet portion151 in response to movement of thecollet122 and theplunger assembly170 forces the liquid injection solution through theseal structure160 dissolving the drug into a medicament injection solution which will then be forced out through theneedle141 and into the patient. As thecollet122 andplunger assembly170 continue forward, theplunger170 will eventually contact theseal structure160, which, in a preferred embodiment, causes theseal structure160 to move in the direction of theneedle assembly140. Movement of theseal structure160 would cause any remaining solution within theportion152 to be dispersed through theneedle assembly140, so as to reduce the amount of residual medicament remaining within thechamber150.
• As shown inFIGS. 2A, 2B and 4, a membrane orfilter190 is preferably provided adjacent theneedle assembly140 to prevent any dry medicament particles from clogging the rearward end ofneedle141 prior to an injection operation. Themembrane190 may also serve to slightly restrict or slow injection of medicament into the patient, to facilitate more thorough dissolution during injection.
• More particularly, to prevent the passage of undissolved dry medicament to theneedle assembly140, amedicament support190 is preferably provided between the end of thedry compartment152 and theneedle assembly140. Thesupport190 can serve to prevent blockage of theneedle assembly141 by preventing the dry medicament from entering the area surrounding theneedle assembly140 while permitting passage of the mixture of dissolved medicament and liquid injection solution. Thesupport190 may be configured as described in U.S. Provisional Application No. 60/238,448, which is herein incorporated by reference in a manner consistent with this disclosure. It is contemplated thatmultiple supports190 may be located within thedry compartment152. The provision of thesupports190 may also improve the laminar flow of the liquid injection solution through the dry medicament thereby improving dissolution.
• Further, a diaphragm assembly (not shown) may also be provided adjacent themedicament support190, as known in the art. The diaphragm assembly acts to prevent the passage of the liquid injection solution to theneedle assembly140 prior to activation of theactuator assembly120. More particularly, the diaphragm assembly will not rupture until either the butt end of theneedle assembly140 ruptures the expanded diaphragm or sufficient pressure builds in thedry compartment160 to rupture the diaphragm, again as known in the art.
• As described above, the movement of thecollet122 causes theinjection needle141 of theinjection assembly140 to advance and protrude through thehousing110. As such, the injection of the medicament can be performed with a simple operation. In sum, the user simply removes theend cap assembly130, locates the injection end of thehousing110 adjacent the injection site, and presses thepush button132. This operation automatically triggers the operation of the drive assembly orspring250 to advance thecollet122 causing the liquid injection solution located within thewet portion151 to enter thedry portion152 through theseal structure160. The dissolved medicament is then transmitted through theinjection needle141 to provide the user with the necessary dose of medicament. Theautomatic injector10 in accordance with the present invention reduces the amount of time required to administer medicament compared to other wet/dry injectors and eliminates the need for mixing by the user.
• Theseal structure160 advantageously enables the manufacture of a superior wet/dry auto injector with a complementary combination of components that are either known in the art of conventional auto-injectors or are otherwise relatively simple to manufacture. Theseal structure160 enables sufficient mixing of wet and dry medicament components without requiring manual shaking. This mixing action is enhanced by the filter ormembrane164. In a preferred embodiment, thefilter164 is a supported, hydrophobia acrylic copolymer cast on a non-woven nylon support Preferably, it is a FlouRepel treated membrane for superior oleoplhobicity/hydro-phobicity.
• In another embodiment, shown inFIG. 7, the automatic injector cartridge includes aneedle assembly140 located within thedry portion152. Theneedle assembly140 extends within thedry portion152 to the sealingstructure180, described above in connection withFIGS. 5A-5D. The sealingstructure180 separates thedry portion152 from thewet portion151. As shown inFIG. 7, the cartridge further includes aplunger170 positioned therein. Theplunger170 is configured to engage thecollet122 of theactivation assembly120. The cartridge includes asheath301. Like thesheath202, thesheath301 maintains theneedle141 in a sterile environment until it projects from the end of thesheath301 in response to activation of theactivation assembly120. During operation, theneedle assembly140 passes through thedry portion152 as the wet medicament passes through the scalingstructure180.
• In other embodiments (seeFIGS. 8A and 8B), noinner plug166 is provided. Rather, theouter structure180 is simply complemented by aseal membrane226 that extends across the inner area defined by the inner surface of the outer structure. When thechamber150 reaches the forward end of the housing during an injection operation, pressurization of thewet compartment151 causes theseal membrane226 to rupture, thereby allowing theseal structure160 to permit liquid to pass therethrough. In this embodiment, it may be desirable to provide theseal structure160 with apointed member228 disposed adjacent to theseal membrane226 to facilitate rupturing of the seal membrane upon pressurized expansion thereof during an injection operation. Themember232 on which the pointedmember228 is mounted has a plurality ofpassages234 that permits fluid to pass therethrough. Filter ormembrane164 is preferably mounted distal to thepassages234 to present laminar or distributed flow to the dry medicament.
Examples
• An injector according to the present invention was loaded with liquid injection solution and dry medicament and activated with the follow results.

• Loaded	Dispensed	Operational

  Dry Powder

  Fluid

  Dry Powder

  Fluid

  Time

  Mg	Ml	%	mg	ml	Secs.

  531	2.7	94	497	2.3	4.0
  557	2.7	93	515	2.3	4.5
  582	2.6	92	537	2.2	4.4

• Other embodiments and modifications of the invention are also contemplated For example, a cover assembly, described for example in U.S. Pat. No. 5,295,965 (the disclosure of which is specifically incorporated herein by reference) may be secured to the injection end of thehousing110 after deployment of the medicament Furthermore, the automatic injector may further include a nipple plunger assembly, as described for example in U.S. Pat. No. 5,713,866 (the disclosure of which is specifically incorporated herein by reference).
• In yet a further embodiment, the forwarddry chamber152 contains theneedle141, as shown inFIG. 7. Theneedle141 is forced through a forward plug stopper upon initial compression of the two chamber system. As known in the art, providing theneedle141 in theforward chamber152 provides improved longitudinal compactness of the design.
• In yet another embodiment, a pre-filled syringe is provided with the seal structure disposed between wet and dry components.
• In further contemplated embodiments, theseal structure160 can be used in the same type of injector described herein, except rather than employing a dry (powder) medicament separated by a liquid component, a first liquid medicament is separated from a second fluid component by theseal structure160. In yet another embodiment, theseal structure160 can be used in what is known in the art as a “needleless injector” where an injection can be made into a patient without a needle or cannula.
• FIG. 9 is a longitudinal cross-sectional view of achamber350 mounted to aneedle assembly340 according to a further embodiment of the invention. Neither ahousing110 nor anactuator assembly120 is shown inFIG. 9; however, thechamber350 andneedle assembly340 may be used with thehousings110 andactuator assemblies120 described above or with substantially any known housing or actuator assembly.
• In thechamber350 andneedle assembly340 shown inFIG. 9, many of the components are the same as those described above with respect toFIG. 1; therefore, the description above will suffice for those components.
• Like thechamber150, thechamber350 has a wet portion orcompartment151 and a dry portion orcompartment152. A sealingstructure360 separates thewet portion151 and thedry portion152. The sealingstructure360 includes anouter sealing member380, amoveable sealing plug166, a by-pass zone165, and may also include a filter ordispersion membrane164, Although amoveable sealing plug166 is shown inFIG. 9, the sealingstructure360 may include arupturable seal membrane226 instead of a sealingplug166, as shown inFIGS. 8A and 8B.
• FIG. 10 is a perspective view of the outer sealingmember380.FIG. 1 is a front elevational view of the sealingmember380, andFIG. 12 is a sectional view of the outer sealingmember380 taken through Line12-12 ofFIG. 11. As shown, the outer sealingmember380 has anannular wiper portion382 that makes sealing contact with the inner wall of thedry portion152 of thechamber350 and extends axially forwardly, in the direction of actuating movement along the longitudinal axis of thechamber350, toward theneedle assembly140.
• While theouter sealing members130 that were described above do form a seal with the inner wall of thecontainer150, during the actuation process, powder from the dry medicament in thedry portion152 tends to accumulate around the sealingmember180,380 at the seal/container interface. As the device actuates, some of the powder that accumulates around the sealingmember180,380 can be driven or forced into the space between the glass and the sealingmember180. The entire area around and between the sealingmember180 and the inner wall of thecontainer150 can become a “dead space,” in which accumulated powder cannot properly mix with fluid.
• Thewiper portion382 helps to eliminate the accumulation of powder around the sealingmember380 by “wiping” or “scraping” any accumulated powder away from the wall of thechamber350 and directing it radially inwardly, where it can properly mix with the wet medicament portion as the sealingmember380 passes through thedry portion132. As shown inFIG. 9, thewiper portion382 makes contact with the inner wall of thedry portion132 of the chamber330 along substantially the entirety of its length. The extent of contact between thewiper portion382 and the inner wall of thedry portion152 is possible, at least in part, because thewiper portion382 extends axially. Although it would be possible to construct a wiping structure that extended radially or angularly outward from the main body of the sealingmember380, such a wiping structure would not be in contact with the inner wall of thedry portion152 over substantially the entirety of its length. Therefore, it would be possible for such a putative wiping structure to cause an undesirable accumulation of medicament powder, particularly if medicament powder were to move past it and into the space between it and the inner wall of thedry portion152. Accordingly, the straight, forwardly-extendingwiper portion382 is currently preferred.
• Awiper portion382, although shown in the embodiment ofFIG. 9, may be used in any of the embodiments shown and described above and in any variations thereof.
• As shown inFIG. 9, thechamber350 has an “open mouth” configuration; i.e., the container itself does not taper substantially as it meets the needle assembly340 (for example, as compared with the embodiment shown inFIG. 3A). The advantages of having an “open mouth” container were described above with respect to thecontainer150. If the “mouth” of the container (i.e, the opening into thedry portion152 of the container) is open and wide, it becomes easier to load the dry component of the medicament. However, having a tapered portion adjacent to theneedle assembly340 helps to direct the medicament radially inwardly, toward theneedle assembly340, when the injection is taking place.
• In order to realize the advantages of an “open mouth” container and the advantages of a tapered container, thechamber350 includes a taperedinsert384 at its mouth, just behind theneedle assembly340.FIG. 13 is a perspective view of the taperedinsert384,FIG. 14 is a front elevational view, andFIG. 15 is a sectional view through Line15-15 ofFIG. 14.
• Thetapered insert384 tapers radially inwardly as it extends axially forwardly, such that it forms afunnel portion386 with a smallcentral opening388 at one end. Thetapered insert384 also has a rearwardopen end389 with a larger open diameter. Theinsert384 sealingly engages the walls of thechamber350. Extending radially outward from the outer surface of thefunnel portion386 proximate to the smallcentral opening388 is anannular sealing flange390. In the embodiment shown inFIGS. 13-15, theannular sealing flange390 is an integral portion of the taperedinsert384. However, in some embodiments, theannular sealing flange390 may be joined to thefunnel portion386 by adhesives or other securing methods. Additionally, as will be described in more detail below, in some configurations, theannular sealing flange390 may be absent. Theinsert384 is preferably formed from a material that will not react with the dry medicament stored in thecompartment152.
• Thechamber350 andneedle assembly340 include a metallic skirt, generally indicated at392, that is rolled or crimped so as to capture or secure theneedle assembly340 to the front end of the chamber330. In this embodiment, theannular sealing flange390 fits between thechamber350 andneedle assembly340 so as to form a seal between them. Either theannular sealing flange390 itself or, depending on the configuration, the entiretapered insert384 may be made of an elastomeric or other rubber material suitable for sealing.
• Thetapered insert384 may be removed from thechamber350 in order to effect the loading of the dry medicament and then inserted into thechamber350 prior to joining with theneedle assembly340. Although the taperedinsert384 is shown with afunnel portion386 of constant, radially inward taper, the tapering of the taperedinsert384 may be of any type that will facilitate fluid flow from thechamber350 into theneedle assembly340.
• At the forward end of the taperedinsert384, the small,central opening388 in theinsert384 is covered by afilter190 that is positioned between thetapered insert384 and theneedle support343 to filter fluids passing from thechamber350 into theneedle assembly340, so as to prevent any undissolved medicament from entering theneedle assembly340. Forward of thefilter190, defined by the rearward (container-facing) side of theneedle support343 is achamber394 that tapers radially inwardly toward its forward end. Thechamber394 is contoured to expose a substantial portion of the surface area of thefilter190 to the flow between thechamber350 and theneedle assembly340. Preferably, thechamber394 has an opening at least as large as the smallcentral opening388 in the taperedinsert384. In the embodiment shown inFIG. 9, thechamber394 is substantially hemispherical, although other configurations may be used. Thechamber394 can be seen more clearly inFIG. 16, which is a longitudinal cross-sectional view of a portion of theneedle assembly340. Thechamber394 allows greater, more laminar, and more fully developed flow through thefilter190 to theneedle141. Furthermore, thechamber394 is shaped to direct the flow of medicament to theneedle141.
• As is also shown inFIG. 16, neither theneedle141 nor any other structure protrudes into thechamber394. Although it would be possible to construct achamber394 and needle assembly such that a portion of the end of the needle protruded into thechamber394, such an arrangement might cause turbulent flow around the end of the needle that protruded into thechamber394, or might otherwise eliminate some of the benefits of thechamber394.
• The sealingmember380 withwiper portion382, taperedinsert384, andchamber394 may all be used in a wet/wet autoinjector assembly that includes two fluid medicament components. In a wet/wet autoinjector assembly, a burstable membrane is typically positioned over the opening of the compartment adjacent to the needle assembly, in order to prevent fluid in that compartment from leaking out of the compartment and into the needle assembly. If the sealingmember380, taperedinsert384, andchamber394 are provided in a wet/wet autoinjector assembly, a burstable membrane may be provided as a portion of the taperedinsert384. For example, the burstable membrane could be positioned in thefunnel portion386 of the insert.
• The sealingmember380, taperedinsert384, andchamber394 may also be used in a wet/dry or wet/wet autoinjector assembly that does not include all of the features described above. For example, the taperedinsert384 andchamber394 may be used in any wet/dry or wet/wet autoinjector in order to improve the loading and dispensing performance of the autoinjector.
• A chamber for an autoinjector may be filled with appropriate medicament components in several different ways. For example, one common way to fill an autoinjector chamber is to fill a first medicament (e.g., a wet medicament) through an opening in the chamber and then fill a second medicament (e.g., a dry medicament) through that same opening in the chamber. This process, while common, tends to cause cross-contamination because both wet and dry medicaments are filled through the same opening. For example, if a dry powder medicament is filled first, any powder that accumulates around the opening may mix with a subsequently-filled wet medicament, thereby contaminating the contents of the wet compartment Conversely, if the wet medicament is filled first, liquid that accumulates around the opening may mix with some of the subsequently-filled dry medicament, thereby contaminating the contents of the dry compartment.
• However, using achamber150,350 according to the invention, it is advantageous to fill thechamber150,350 using a separate opening in thechamber150,350 for each type of medicament, thus eliminating the cross-contamination problem. This sort of filling process for achamber150,350 includes a number of tasks and will be described below with respect to thechamber350, although the described process is, in general, equally applicable to the other embodiments described above. Ordinarily, the filling process would be performed in an aseptic environment.
• Typically, thechamber350 is initially open at both ends and does not include any interior structures, as shown inFIG. 17A. A seal structure, such asseal structure360, is first inserted into thechamber350 so that it is positioned substantially as shown inFIG. 17B.
• Once theseal structure360 is in place, thechamber350 is removed to or placed in a low particulate aseptic environment, and is positioned so that the wet portion orcompartment151 can be filled through anopening396 in the rear end of thechamber350, as shown inFIG. 17C. (The low particulate environment prevents possible cross-contamination of thewet portion151.) After thewet portion151 is filled, theopening396 in the rear end of thechamber350 is sealed by installing theplunger170, as shown inFIG. 17D. The placement of thechamber350 in a low particulate environment prior to filling thewet portion151 helps to prevent contamination of thewet portion151 by powder or other participates.
• Once thewet portion151 is filled with the desired liquid medicament portion and the rear end is sealed with theplunger170, thechamber350 is removed from the low participate environment and is placed in an appropriate aseptic environment so that the dry portion orchamber152 of thechamber350 can be filled through anopening398 in the front of thechamber350. There are two common ways of filling thedry portion152. One way to fill thedry portion152 is to place a dry powder directly into thedry portion152 through theopening398, as shown inFIG. 17E.
• Another way to fill thedry portion152 is to fill thedry portion152 with a liquid medicament through theopening398 and then lyophilize the liquid medicament directly in thedry portion152 to leave only the desired dry medicament. While this process of liquid filling and lyophilizing may be used, it sometimes leaves residues in thedry portion152, which may interfere with the stability of the dry medicament or otherwise contaminate.
• A third way to fill thedry portion152 is to lyophilize a liquid medicament in a separate container to form a lyophilizeddry medicament tablet400 and then deposit thedry medicament tablet400 in thedry portion152 through theopening398, as shown inFIG. 17F. This variation of the filling process is used most advantageously with a chamber that has a relatively wide opening into its dry portion, so that tablets of various sizes can be accommodated. If a chamber has a relatively narrow opening into its dry portion, it may be necessary to fill that dry portion with powder, or to lyophilize a liquid medicament directly in the dry portion to form a dry powder.
• After thedry portion152 is filled, atapered insert384 is placed in opening398 of thechamber350 and theneedle assembly340 is secured over the taperedinsert384. When the process is complete, thechamber350 is as shown inFIG. 9.
• Although the present invention has been described with respect to a number of embodiments, those embodiments are meant to be illustrative, rather than limiting. As those of ordinary skill in the art will understand, modifications and variations are possible within the scope of the appended claims.

Claims (20)

We claim:

1. An automatic injection device for automatically administering a medicament upon actuation thereof, the device comprising:

a housing;

a chamber disposed in the housing and having a first compartment and a second compartment;

a seal structure between the first compartment and the second compartment, the seal structure initially in a sealing condition that seals the first compartment from the second compartment, the seal structure comprising a plug and an outer sealing member that forms a peripheral seal with an interior wall of the chamber, wherein the plug is slidably movable within the outer sealing member to convert the seal structure from the sealing condition to a mixing condition by opening a path between the first compartment and the second compartment through the seal structure, the plug maintaining the same orientation with respect to the outer sealing member as the plug moves to convert the seal structure from the sealing condition to the mixing condition;

a needle assembly connected to the first compartment; and

an activation assembly carried by the housing, wherein activation of the activation assembly causes (1) pressurization of the first compartment, (2) the seal structure to convert from the sealing condition to the mixing condition, and (3) the first and second medicament components to be mixed and forced through the needle assembly.

2. The automatic injection device ofclaim 1, wherein activation of the activation assembly also causes the plunger to contact and move the seal structure through the first compartment toward the needle assembly.

3. The automatic injection device ofclaim 1, further comprising a plunger that rearwardly seals the second compartment.

4. The automatic injection device ofclaim 1, wherein the seal structure further comprises a fluid distributing member that creates a laminar fluid flow into the first compartment from the second compartment after the automatic injection device has been activated causing pressurization of the first compartment.

5. The automatic injection device ofclaim 1, wherein the seal structure further comprises an annular wiper portion disposed at a front end of the seal structure and extends axially, the wiper portion positioned to engage an interior wall of the first compartment and configured to direct dry medicament particles engaged with the interior wall radially inward as the seal structure moves through the first compartment.

6. The automatic injection device ofclaim 5, wherein the wiper portion comprises a peripheral lip having an inner surface that extends radially inward as it extends axially rearward.

7. The automatic injection device ofclaim 1, further comprising an insert mounted in a front end of the chamber adjacent the needle assembly, the insert defining a tapering flow pathway that tapers radially inwardly as it extends axially forward.

8. The automatic injection device ofclaim 7, wherein the needle assembly comprises a needle support for mounting the needle assembly to the front end of the chamber, the needle support defining a needle assembly chamber having an enlarged rearward end opening of a size that is at least as large as a front end opening of the insert.

9. The automatic injection device ofclaim 7, further comprising a filter positioned between the needle assembly and the insert.

10. The automatic injection device ofclaim 1, wherein the first compartment comprises a dry medicament component and the second compartment comprises a liquid medicament component.

11. An automatic injection device containing a medicament for automatically administering the medicament upon actuation thereof, the device comprising:

a housing;

a chamber disposed in the housing and having a first compartment and a second compartment;

a seal structure between the first compartment and the second compartment, the seal structure initially in a sealed condition to maintain the first compartment separate from the second compartment, the seal structure converting to a mixing condition in response to activation of the device, the seal structure including:

an outer sealing member that forms a peripheral seal with an interior wall of the chamber, and

a plug spaced radially inward from the outer sealing member, the plug in a first position wherein the plug is sealingly engaged with a surface of the outer sealing member to form a liquid-tight seal between the first and second compartments when the seal structure is in the sealed condition, the plug in a second position when the seal structure is in the mixing condition, the plug remaining stationary in the second position as the liquid component flows through the seal structure and thereafter;

a needle assembly connected to the chamber; and

an activation assembly disposed in the housing wherein activation of the activation assembly causes (1) pressurization of the first compartment, (2) the seal structure to convert from the sealed condition to the mixing condition, and (3) contents of the first and second compartments to be mixed and forced through the needle assembly.

12. The automatic injection device ofclaim 11, wherein the first compartment comprises a dry medicament component and the second compartment comprises a liquid medicament component.

13. The automatic injection device ofclaim 12, further comprising a dispersion membrane through which the liquid medicament component flows when the seal structure is in the mixing condition after the automatic injection device has been activated causing pressurization of the first compartment.

14. The automatic injection device ofclaim 13, wherein the dispersion membrane comprises a hydrophobic acrylic copolymer cast on a non woven nylon support.

15. The automatic injection device ofclaim 11, wherein the seal structure further comprises an annular wiper portion disposed at a front end of the outer sealing member and extends axially, the wiper portion positioned to engage an interior wall of the first compartment as the seal structure is moved through the first compartment, the wiper portion configured to direct dry medicament particles engaged with the interior wall radially inward as the seal structure moves through the first compartment when in the mixing condition.

16. The automatic injection device ofclaim 15, wherein the annular wiper portion comprises a peripheral lip having an inner surface that extends radially inward as it extends axially rearward.

17. The automatic injection device ofclaim 11, wherein the outer sealing member comprises an O-ring that provides an annular seal with the interior wall of the chamber.

18. The automatic injection device ofclaim 11, wherein the seal structure has a by-pass zone adjacent the plug in the first position and around the plug in the second position.

19. The automatic injection device ofclaim 11, further comprising a plunger rearwardly sealing the second compartment, wherein activation of the activation assembly causes the plunger to contact and move the seal structure through the first compartment toward the needle assembly.

20. The automatic injection device ofclaim 11, further comprising an insert mounted in a front end of the chamber adjacent the needle assembly, the insert defining a tapering flow pathway that tapers radially inwardly as it extends axially forward.

Images